The National Taiwan University Hospital is a medical facility located in the Zhongzheng District of Taipei, Taiwan. It started operations under Japanese rule in Daitōtei on 18 June 1895, and moved to its present location in 1898.

There are 2,400 beds in Department of Urology/National Taiwan University Hospital.

During the past decade, Department of Urology/National Taiwan University Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Urology/National Taiwan University Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "National Taiwan University Hospital" with 3 trials sponsored, "Health Ever Bio-Tech Co., Ltd." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Société Internationale d'Urologie" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Urology/National Taiwan University Hospital" #1 collaborator was "Cardinal Tien Hospital" with 1 trials as a collaborator, "Chang Gung Memorial Hospital" with 1 trials as a collaborator, "Far Eastern Memorial Hospital" with 1 trials as a collaborator, "Shin Kong Wu Ho-Su Memorial Hospital" with 1 trials as a collaborator and "Taichung Tzu Chi Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Department of Urology/National Taiwan University Hospital" are "Bladder Urothelial Carcinoma" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Overactive Bladder" (1 trials), "Prostate Cancer" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Department of Urology/National Taiwan University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Urology/National Taiwan University Hospital" are "Drug" (5 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (3 trials), "Enzalutamide" (1 trials), "Fesoterodine 4mg" (1 trials) and "Fesoterodine 8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Urology/National Taiwan University Hospital" are 6 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Urology/National Taiwan University Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Department of Urology/National Taiwan University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Urology/National Taiwan University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".